WCG acquires CTMS internet platform for its growing network

By Maggie Lynch

- Last updated on GMT

(Image:Getty/Urupong)
(Image:Getty/Urupong)
WCG acquires Velos’ CTMS internet platform to provide drug development and research management to its large institutional research network.

WIRB-Copernicus Group (WCG) clinical service division’s acquisition of Velos eResearch will give WCG’s network access to clinical research simplification capabilities through clinical trial management software.

Velos eResearch manages institutional research by housing study status, patient enrollment, calendars, budgets, billing, and electronic data capture in one place. The company states the platform increases efficiency, transparency and accessibility of institutional research.

According to WCG, it partners with 93% of institutions and 90% of the academic medical centers that conduct research in the US. Donald Deieso, executive chairman and CEO of WCG, stated that the group serves more than 2,800 institutions.  

Through this partnership with the institutions, WCG states it facilitates drug development, providing solutions to increase efficiency and profitability of their research, as well as accelerating patient enrollment.

John McIlwain, co-founder and CEO of Velos, said that its clients are a “critical part of the clinical research ecosystem. It is our mission to break down the silos and administrative barriers slowing their progress and limiting their growth, to enable them to accelerate breakthroughs in clinical care.”

Velos will operate independently and retain its headquarters in Fremont, California. WCG will support Velos with access to capital, expertise and corporate operational support.

WCG has acquired and collaborated with multiple companies to expand its pharmacovigilance​, trial benchmarking​, and data monitoring​ services. 

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Products

View more

Webinars